Pages that link to "Q33772820"
Jump to navigation
Jump to search
The following pages link to Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression (Q33772820):
Displaying 34 items.
- Genome-wide matching of genes to cellular roles using guilt-by-association models derived from single sample analysis (Q21199585) (← links)
- Folliculin interacts with p0071 (plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesis (Q24298493) (← links)
- Metabolism of kidney cancer: from the lab to clinical practice (Q24600512) (← links)
- Genomics of chromophobe renal cell carcinoma: implications from a rare tumor for pan-cancer studies (Q26851787) (← links)
- Metastatic renal cell carcinoma: update on epidemiology, genetics, and therapeutic modalities (Q26852437) (← links)
- Folliculin regulates ampk-dependent autophagy and metabolic stress survival (Q27316476) (← links)
- Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN (Q28506632) (← links)
- Renal cell cancer: overview of the current therapeutic landscape. (Q30248354) (← links)
- The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation (Q33685916) (← links)
- Gene expression in archived newborn blood spots distinguishes infants who will later develop cerebral palsy from matched controls (Q35150986) (← links)
- Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn (Q35279496) (← links)
- Pulmonary manifestations of Birt-Hogg-Dubé syndrome. (Q35536837) (← links)
- Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors (Q36235955) (← links)
- Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome (Q36283086) (← links)
- Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression (Q36544967) (← links)
- Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies (Q36799958) (← links)
- Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome (Q37429054) (← links)
- The PGC-1/ERR signaling axis in cancer (Q38064784) (← links)
- Tumour and patient factors in renal cell carcinoma-towards personalized therapy (Q38418649) (← links)
- Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome. (Q38725502) (← links)
- Oncocytoma-like renal tumor with transformation toward high-grade oncocytic carcinoma: a unique case with morphologic, immunohistochemical, and genomic characterization (Q39128955) (← links)
- Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome (Q40519705) (← links)
- Functional aspects of primary cilia in signaling, cell cycle and tumorigenesis (Q40963789) (← links)
- Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome (Q41566823) (← links)
- RNA sequencing reveals upregulation of RUNX1-RUNX1T1 gene signatures in clear cell renal cell carcinoma (Q42361297) (← links)
- Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours (Q42642212) (← links)
- Loss of the Birt-Hogg-Dubé gene product folliculin induces longevity in a hypoxia-inducible factor-dependent manner (Q44159799) (← links)
- Birt-Hogg-Dubé syndrome: spontaneous pneumothorax as a first symptom (Q47555459) (← links)
- FLCN: The causative gene for Birt-Hogg-Dubé syndrome (Q47712748) (← links)
- Conserved and Divergent Features of Mesenchymal Progenitor Cell Types within the Cortical Nephrogenic Niche of the Human and Mouse Kidney (Q49959878) (← links)
- Loss of Fnip1 alters kidney developmental transcriptional program and synergizes with TSC1 loss to promote mTORC1 activation and renal cyst formation. (Q55500213) (← links)
- The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy (Q64237577) (← links)
- Classification of solid renal tumor with oncocytic/eosinophilic cytoplasm: is hybrid oncocytic/chromophobe renal tumor a subtype of oncocytoma, chromophobe renal cell carcinoma, or a distinct tumor entity? (Q89521073) (← links)
- Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma (Q92969752) (← links)